Found 0 matching trials
Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics
PHASE1To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Location
Human Pharmacology Unit (UFH)
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
PHASE2The primary objective of this study is to explore the efficacy and tolerabi...
Location
Multiple Locations
Real-Time Levodopa Level Monitoring in Parkinson Disease
NAThis project aims to develop a minimally invasive sensor device to monitor ...
Location
University of California San DIego
Pharmacokinetic Study With Repeated Doses of Stalevo
PHASE1The purpose of this study is to show that higher minimum concentration valu...
Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease
PHASE4The main goal of PD research is to develop disease-modifying drugs to delay...
Location
Second Affilliated Hospital Zhejiang University
Sleepiness in Parkinson's Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation
N/ASleepiness is frequent in parkinsonian patients, increasing with the durati...
Location
Nancy University Hospital
The Effect of Dopamine on Diabetic Retinopathy
PHASE1The purpose of this study is to evaluate the use of electroretinogram (ERG)...
Location
Atlanta VA Medical Center
Fexofenadine as Adjuvant Therapy in Parkinson Disease
PHASE2Parkinson's disease (PD) is a chronic, progressive neurological disorder ch...
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
PHASE3The primary objective of this study is to provide continued access to levod...
Location
University of Alabama at Birmingham /ID# 49941
Histaminergic Basis of Fatigue in Multiple Sclerosis
PHASE2The purpose of this research study is to identify a way to improve the feel...
Location
University of Miami